Product NDC: | 10370-175 |
Proprietary Name: | Fluvoxamine Maleate |
Non Proprietary Name: | Fluvoxamine Maleate |
Active Ingredient(s): | 100 mg/1 & nbsp; Fluvoxamine Maleate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10370-175 |
Labeler Name: | Par Pharmaceutical, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091476 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130313 |
Package NDC: | 10370-175-11 |
Package Description: | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-175-11) |
NDC Code | 10370-175-11 |
Proprietary Name | Fluvoxamine Maleate |
Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-175-11) |
Product NDC | 10370-175 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fluvoxamine Maleate |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130313 |
Marketing Category Name | ANDA |
Labeler Name | Par Pharmaceutical, Inc. |
Substance Name | FLUVOXAMINE MALEATE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |